文献速递胸部肿瘤

2000至2017年欧洲和北美年龄与性别特异性肺癌死亡率趋势:基于世界卫生组织死亡数据库生命登记数据的分析

Trends in age- and sex-specific lung cancer mortality in Europe and Northern America: Analysis of vital registration data from the WHO Mortality Database between 2000 and 2017.
PubMed 文献 · Eur J Cancer · 2022-06-20

该研究利用世界卫生组织死亡数据库2000至2017年欧洲和北美生命登记数据进行时间趋势分析,采用泊松自回归模型计算平均年度百分比变化(AAPC)。结果显示总体年龄标化肺癌死亡率年均下降1.5%,男性年均下降2.3%,女性年均下降0.3%且该轻微下降仅由美国驱动,31个国家中21个女性肺癌死亡率显著上升。

要点

  • 2000至2017年总体年龄标化肺癌死亡率年均下降1.5%,男性年均下降2.3%,女性年均下降0.3%。
  • 女性肺癌死亡率轻微下降仅由美国驱动,31个国家中21个女性肺癌死亡率显著上升。
  • 西班牙女性肺癌死亡率AAPC为4.1%,法国为3.6%,居女性死亡率上升国家前列。

核心结论

  • 尽管肺癌死亡率总体呈下降趋势,但除美国外所有国家女性肺癌死亡率保持不变或显著上升。
  • 国家间死亡率结局差异反映了烟草控制、筛查、治疗进展和医疗可及性的不同。

研究设计与样本

  • 研究为时间趋势分析,使用世界卫生组织死亡数据库2000至2017年北美和欧洲的生命登记数据。
  • 采用人群平均泊松自回归分析评估肺癌死亡率改善情况,以平均年度百分比变化(AAPC)作为总体及国家特异性死亡率趋势的汇总指标。
  • 研究还分析了肺癌发病率和吸烟率的时间趋势。

主要发现

  • 肺癌被报告为主要死因的情况为每100例死亡中5.4例。
  • 2000至2017年年龄标化死亡率持续下降,AAPC为-1.5%。
  • 男性死亡率年均下降2.3%,女性死亡率年均下降0.3%,女性这一轻微下降仅由美国驱动。
  • 2000至2017年31个国家中有21个女性肺癌死亡率显著上升,西班牙(AAPC 4.1%)和法国(AAPC 3.6%)居前。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In the context of new targeted therapies and immunotherapy as well as screening modalities for lung cancer patients, detailed mortality trends in Europe and Northern America are unknown. METHODS: Time-trend analysis using vital registration data of Northern America and Europe from the WHO Mortality Database (years 2000/2017). To assess improvements in lung cancer mortality, we performed a population-averaged Poisson autoregressive analysis. The average annual percent change (AAPC) was used as a summary measure of overall and country-specific trends in mortality. Second, we studied time trends of lung cancer incidence and smoking prevalence rates. FINDINGS: In the total population of 872·5 million people between 2015 and 2017, the average annual age-standardised mortality from lung cancer was 54·6 deaths per 100 000, with substantial differences across countries. Lung cancer was reported as the primary cause of death in 5·4 cases per 100 deaths. The age-standardised mortality rate decreased constantly (AAPC -1·5%) between 2000 and 2017. While mortality in men dropped annually by an average of -2·3%, mortality in women decreased by an average of -0·3%. This slight decline was driven exclusively by the USA. In contrast, 21 out of 31 countries registered a significant increase in female lung cancer mortality between 2000 and 2017, with Spain (AAPC 4·1%) and France (AAPC 3·6%) leading the list. INTERPRETATION: Despite overall decreases in lung cancer mortality trends, female mortality remained unchanged or increased significantly in all countries except the USA. National mortality outcomes reflect variabilities in tobacco control, screening, therapeutic advances, and access to health care.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Baum P, Winter H, Eichhorn ME, et al. Trends in age- and sex-specific lung cancer mortality in Europe and Northern America: Analysis of vital registration data from the WHO Mortality Database between 2000 and 2017. Eur J Cancer. 2022. PMID: 35738973. doi:10.1016/j.ejca.2022.05.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。